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Capsular hyaluronic acid of cryptococcus
neoformans contributes to fungal invasion
across the alveolar-capillary interface
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1 Southern Medical University, Guangzhou, China
2 Southern Medical University, Guangzhou,
Guangdong, China
Background: Cryptococcus neoformans infection has signif-
icantly increased recently, particularly in AIDS patients and
immunocompromised individuals. At present, it is unclear how
C. neoformans traversesthe alveolar-capillary interface and causes
infection. Previous study has show that C. neoformans capsular
hyaluronic acid (HA) was a virulent factor and CD44 is the major
HA receptor on HBMEC during C. neoformans infection.
Methods & Materials: Our study examined and character-
ized the interaction of C. neoformans with human pulmonary
microvascular endothelial cells (HPMEC), which constitute the
alveolar-capillary barrier. Cryptococcus neoformans wild-type and
CPS1 gene mutant (HA-deﬁcient strains) were used to infect
HPMEC. Immune suppressed mice model was also used. Then, the
ability to associate with HPMEC was done by fungi counting. CD44
expression and actin rearrangement of HPMEC were observed by
the immunoﬂuorescent techniques. Balb/cmicewere immunosup-
pressed with cyclophosphamide (CTX), and inhaled Cryptococcus
neoformans using ultrasonic atomized inhalation. The number
of CFU of Cryptococci was quantized in blood and brain. CD44
expression in lung tissue was examined by the immunoﬂuorescent
method.
Results: We found that C. neoformans association with HPMEC
was reduced apparently using CPS1 mutant strains. Expression
of CD44 signal was increased in membrane of HPMEC infected
by C. neoformans but no change infected by CPS1 mutant strain.
C. neoformans CPS1 mutant strain was less virulent in inducing
actin cytoskeleton change of HPMEC. And C. neoformans infec-
tion increased the expression of CD44 signal in lung tissue of the
immunosuppressive Balb/c mouse and caused the fungal invasion
across the alveolar-capillary interface into blood.
Conclusion: Our results suggest that the capsular hyaluronic
acid (HA) contributes to Cryptococcus neoformans penetrating
across the alveolar-capillary barrier.
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Candidemia and coincidental
pseudomembranous tracheobronchial
aspergillosis
A. Gloeckner ∗
BDH-Klinik Greifswald, Greifswald, Germany
Background: Invasive mycoses in intensive care patients are
commonly due to yeasts. During the past years, infections with
non-albicans species, uncommon yeasts and molds have gained
importance.
Methods & Materials: Case report
Results: A 75 years old male was admitted into hospital for
acute myocardial infarction. The medical history included chronic
obstructive pulmonary disease under long-term systemic and top-
ical glucocorticoid therapy, and pulmonary tuberculosis 60 years
ago.On day 2, the patient underwent coronary bypass surgery
complicated by cardiogenic shock with acute renal failure. For a
systemic infection, he was treated with Meropenem for 10 days.
During this treatment, Candida albicans and Aspergillus fumiga-
tus were cultured from tracheal secretions. Candida albicans was
isolated from blood culture and central venous catheter tip simul-
taneously. Fiberoptic bronchoscopy revealed several extended
cream-colored plaques on the mucosa of trachea, carina and right
main bronchus. Aspergillus fumigatus was cultured from tracheal
secretions repeatedly and in large quantity.
Antimycotic therapywas initiatedwithCaspofungin.Due to lack
of clinical improvement, persistently positive tracheal Aspergillus
cultures, and another blood culture positive for Candida albicans,
therapy was changed to Voriconazole. After 7 days of intravenous
application, Voriconazole was continued enterally for another ﬁve
weeks. Overall clinical status of the patient and appearance of the
mucosal lesions improved, and further cultures were negative for
fungi. After 3months, thepatientwas transferred to a rehabilitation
facility.
Conclusion: In a patient with multi-organ failure complicating
acute myocardial infarction, a combined invasive fungal infec-
tion with pseudomembranous tracheobronchial aspergillosis and
candidemia was successfully treated with a sequential course of
intravenous and enteral Voriconazole.
http://dx.doi.org/10.1016/j.ijid.2014.03.1006
